Search company, investor...

Receptor+

receptor.ca

Stage

Seed | Alive

Total Raised

$1.1M

Last Raised

$500K | 12 yrs ago

About Receptor+

Receptor+ is a Canadian wellness brand that will provide enhanced dietary and topical cannabinoid therapy through the inclusion of our premium, hemp-derived, full-spectrum CBD. Incorporating organically-certified ingredients, Receptor+ enhanced wellness products will include beauty & food items, in addition to new categories, like meal replacements, chewable, and beverages. Its Receptor+ wearable wellness patches will provide lasting transdermal therapy for pain relief and wound care to compliment a line of ointments, creams, and masks.

Headquarters Location

MaRS Centre, South Tower 101 College Street, Suite 100

Toronto, Ontario, M5G 1L7,

Canada

416-673-8153

Missing: Receptor+'s Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Receptor+'s Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Receptor+

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Receptor+ is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Receptor+ Patents

Receptor+ has filed 1 patent.

The 3 most popular patent topics include:

  • Cannabinoids
  • Designer drugs
  • Dietary supplements
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/6/2017

2/15/2022

Cannabinoids, Designer drugs, Piperidines, Rare diseases, Syndromes

Grant

Application Date

10/6/2017

Grant Date

2/15/2022

Title

Related Topics

Cannabinoids, Designer drugs, Piperidines, Rare diseases, Syndromes

Status

Grant

Receptor+ Frequently Asked Questions (FAQ)

  • Where is Receptor+'s headquarters?

    Receptor+'s headquarters is located at MaRS Centre, South Tower, Toronto.

  • What is Receptor+'s latest funding round?

    Receptor+'s latest funding round is Seed.

  • How much did Receptor+ raise?

    Receptor+ raised a total of $1.1M.

  • Who are the investors of Receptor+?

    Investors of Receptor+ include MaRS Investment Accelerator Fund and GrowthWorks.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.